Vitamin D and Sun Exposure: A Community Survey in Australia.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
18 02 2023
Historique:
received: 14 12 2022
revised: 07 02 2023
accepted: 15 02 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Sun exposure carries both harms and benefits. Exposing the skin to the sun is the main modifiable cause of skin cancers, which exert a considerable health and economic burden in Australia. The most well-established benefit of exposure to ultraviolet (UV) radiation is vitamin D production. Australia has the highest incidence of skin cancer in the world but, despite the high ambient UV radiation, approximately one quarter of the population is estimated to be vitamin D deficient. Balancing the risks and benefits is challenging and requires effective communication. We sought to provide a snapshot of public knowledge and attitudes regarding sun exposure and vitamin D and to examine the associations between these factors and sun protective behaviors. In 2020 we administered an online survey; 4824 participants with self-reported fair or medium skin color were included in this analysis. Only 25% and 34% of participants were able to identify the amount of time outdoors needed to maintain adequate vitamin D status in summer and winter, respectively and 25% were concerned that sunscreen use inhibits vitamin D synthesis. This lack of knowledge was associated with suboptimal sun protection practices. Public education is warranted to prevent over-exposure, while supporting natural vitamin D production.

Identifiants

pubmed: 36826149
pii: curroncol30020188
doi: 10.3390/curroncol30020188
pmc: PMC9955356
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2465-2481

Références

J Invest Dermatol. 2018 Oct;138(10):2244-2252
pubmed: 29730334
FASEB J. 2018 Jul;32(7):3700-3706
pubmed: 29394104
J Invest Dermatol. 2020 Jul;140(7):1418-1426.e1
pubmed: 31883961
EBioMedicine. 2017 Feb;15:210-219
pubmed: 28063778
Autoimmun Rev. 2013 Aug;12(10):976-89
pubmed: 23542507
PLoS Med. 2019 Oct 8;16(10):e1002932
pubmed: 31593565
Arch Dermatol. 1995 Apr;131(4):415-21
pubmed: 7726582
Prev Med. 2017 Jun;99:326-331
pubmed: 28322879
Int J Environ Res Public Health. 2012 Jul;9(7):2386-95
pubmed: 22851950
Int J Cancer. 2018 Apr 15;142(8):1528-1535
pubmed: 29105744
Med J Aust. 2006 Jan 2;184(1):6-10
pubmed: 16398622
JBMR Plus. 2021 Jan 19;5(1):e10460
pubmed: 33553995
Photochem Photobiol. 2011 May-Jun;87(3):741-5
pubmed: 21517886
Public Health Res Pract. 2022 Mar 10;32(1):
pubmed: 35290994
Med J Aust. 2012 Jun 18;196(11):686-7
pubmed: 22708765
Br J Nutr. 2019 Apr;121(8):894-904
pubmed: 30674358
Br J Dermatol. 2019 Nov;181(5):907-915
pubmed: 30945275
BMC Public Health. 2006 Sep 07;6:226
pubmed: 16956420
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Chronobiol Int. 2019 Feb;36(2):151-170
pubmed: 30311830
Prev Med. 2010 Apr;50(4):215-6
pubmed: 20153360
Aust N Z J Public Health. 2015 Oct;39(5):471-6
pubmed: 26437734
Int J Cancer. 2012 May 1;130(9):2138-45
pubmed: 21647876
Health Promot J Austr. 2021 Jul;32(3):399-406
pubmed: 32557897
J Am Acad Dermatol. 2006 Nov;55(5):741-60; quiz 761-4
pubmed: 17052479
J Pediatr Gastroenterol Nutr. 2016 Apr;62(4):643-9
pubmed: 26628439
Int J Cancer. 2009 Apr 15;124(8):1963-70
pubmed: 19123471
Prev Med. 2012 Aug;55(2):146-50
pubmed: 22634425
Circ Res. 2009 Nov 6;105(10):1031-40
pubmed: 19797169
Endocr Connect. 2021 Oct 15;10(10):R248-R266
pubmed: 34519278
Photodermatol Photoimmunol Photomed. 2014 Apr-Jun;30(2-3):55-61
pubmed: 24417448
J Natl Cancer Inst. 2018 Oct 1;110(10):1075-1083
pubmed: 29538697
Nat Rev Immunol. 2019 Nov;19(11):688-701
pubmed: 31213673
Nutrients. 2018 Apr 07;10(4):
pubmed: 29642423
Public Health Rep. 2011 Jul-Aug;126(4):533-9
pubmed: 21800747
Adv Exp Med Biol. 2020;1268:19-36
pubmed: 32918212
Cancer Causes Control. 2007 Nov;18(9):1015-9
pubmed: 17641980
Cancer. 2020 May 15;126(10):2225-2249
pubmed: 32162336
Arch Gerontol Geriatr. 2015 Jan-Feb;60(1):134-41
pubmed: 25456887
Lancet. 1999 Aug 28;354(9180):723-9
pubmed: 10475183
PLoS One. 2013 Jun 19;8(6):e65835
pubmed: 23840373
Clin Biochem Rev. 2019 Aug;40(3):147-162
pubmed: 31530965
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1784-9
pubmed: 20570906
Med J Aust. 2017 Oct 16;207(8):339-343
pubmed: 29020905
Photochem Photobiol. 2016 May;92(3):495-502
pubmed: 26914695
Adv Exp Med Biol. 2020;1268:387-405
pubmed: 32918230
N Engl J Med. 1993 Oct 14;329(16):1147-51
pubmed: 8377777
Lancet Diabetes Endocrinol. 2014 Jan;2(1):76-89
pubmed: 24622671
BMC Fam Pract. 2012 Aug 17;13:85
pubmed: 22901028
Public Health Res Pract. 2022 Mar 10;32(1):
pubmed: 35290996

Auteurs

Vu Tran (V)

QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
The University of Queensland, Brisbane, QLD 4006, Australia.

Monika Janda (M)

The University of Queensland, Brisbane, QLD 4006, Australia.

Robyn M Lucas (RM)

The Australian National University, Canberra, ACT 2601, Australia.

Donald S A McLeod (DSA)

QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia.

Bridie S Thompson (BS)

QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Mary Waterhouse (M)

QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

David C Whiteman (DC)

QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
The University of Queensland, Brisbane, QLD 4006, Australia.

Rachel E Neale (RE)

QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
The University of Queensland, Brisbane, QLD 4006, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH